Informační systém MU
VYCHYTILOVÁ, Petra and Ondřej SLABÝ. MicroRNA-215: From biology to theranostic applications. Molecular aspects of medicine. Amsterdam: Elsevier, 2019, vol. 70, DEC, p. 72-89. ISSN 0098-2997. Available from: https://dx.doi.org/10.1016/j.mam.2019.03.002.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name MicroRNA-215: From biology to theranostic applications
Authors VYCHYTILOVÁ, Petra (203 Czech Republic, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Molecular aspects of medicine, Amsterdam, Elsevier, 2019, 0098-2997.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 9.577
RIV identification code RIV/00216224:14740/19:00108155
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1016/j.mam.2019.03.002
UT WoS 000498912100006
Keywords in English miR-215; Proliferation; Cell cycle; Apoptosis; Biomarker; Therapeutic target
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 31/3/2020 21:44.
Abstract
MicroRNA-215 (miR-215) is one of the extensively studied microRNAs (miRNAs) in human diseases, especially in different types of cancer, where it plays various roles in the initiation and progression of tumors. There is also a high conservation of miR-215 among wide range of different species indicating that this miRNA may have vital functions that are maintained during evolution. During the last ten years, significant efforts were dedicated to uncover molecular mechanisms of miR-215 regulation and cellular functioning. In addition, miR-215 was repeatedly identified to have the causal roles in pathology of various diseases, where it may serve as a promising diagnostic, prognostic or predictive biomarker and as a therapeutic target. Here, we overview more than 150 reports focused on miR-215 to allow the synthesis of knowledge on its transcriptional and post-transcriptional regulation, and functioning in essential biological processes like cell and tissue development, cell survival, cell cycle and proliferation, cell migration and invasion, cellular microenvironment communication, and metabolism. Further, we summarized the findings on miR-215 roles in pathology of nonmalignant diseases and various types of cancer with special focus on miR-215 as a promising molecule for future development of theranostic miRNA-based approaches. Although it is difficult to evaluate the full theranostic potential of miR-215, it is probable that during the following years, an increasing number of theranostic miRNA modalities that overcome the current technological obstacles will appear, and enable the translation of miR-215 knowledge into the clinic.
Links
GA16-18257S, research and development projectName: Studium mechanizmu spojeného s nádorově supresorovou funkcí miR-215 a substituce této miRNA jako nové lečebné strategie u kolorektálního karcinomu
Investor: Czech Science Foundation
NV16-31765A, research and development projectName: Využití tkáňových/cirkulujících mikroRNA pro predikci léčebné odpovědi a zpřesnění restagingu karcinomu rekta po neoadjuvantní léčbě
Displayed: 20/7/2024 06:25